How I treat rare venous thromboses

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Venous thromboembolism may involve venous sites other than the lower limbs, such as cerebral, splanchnic, and upper limb veins. Although uncommon, these thromboses may be clinically severe and challenging for caregivers. In this review, the main pathogenic, clinical, and therapeutic features of thromboses in rare venous sites are discussed. Even though there was a lot of recent progress in understanding the mechanistic role of inherited and acquired thrombophilia and of the interactions between different risk factors, the optimal management of these patients is still unsettled, being currently based on the consensus ofexperts due to the lack of randomized trials. The implementation of large interdisciplinary registries is a necessary weapon to optimize the treatment of rare venous diseases.

Original languageEnglish
Pages (from-to)4818-4823
Number of pages6
JournalBlood
Volume112
Issue number13
DOIs
Publication statusPublished - Dec 15 2008

Fingerprint

Venous Thrombosis
Thrombosis
Weapons
Thrombophilia
Viscera
Venous Thromboembolism
Rare Diseases
Upper Extremity
Caregivers
Registries
Lower Extremity
Veins
Therapeutics

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Immunology
  • Hematology

Cite this

How I treat rare venous thromboses. / Martinelli, Ida; Franchini, Massimo; Mannucci, Pier Mannuccio.

In: Blood, Vol. 112, No. 13, 15.12.2008, p. 4818-4823.

Research output: Contribution to journalArticle

Martinelli, Ida ; Franchini, Massimo ; Mannucci, Pier Mannuccio. / How I treat rare venous thromboses. In: Blood. 2008 ; Vol. 112, No. 13. pp. 4818-4823.
@article{09579719ba9e4126916b5da93ad99efc,
title = "How I treat rare venous thromboses",
abstract = "Venous thromboembolism may involve venous sites other than the lower limbs, such as cerebral, splanchnic, and upper limb veins. Although uncommon, these thromboses may be clinically severe and challenging for caregivers. In this review, the main pathogenic, clinical, and therapeutic features of thromboses in rare venous sites are discussed. Even though there was a lot of recent progress in understanding the mechanistic role of inherited and acquired thrombophilia and of the interactions between different risk factors, the optimal management of these patients is still unsettled, being currently based on the consensus ofexperts due to the lack of randomized trials. The implementation of large interdisciplinary registries is a necessary weapon to optimize the treatment of rare venous diseases.",
author = "Ida Martinelli and Massimo Franchini and Mannucci, {Pier Mannuccio}",
year = "2008",
month = "12",
day = "15",
doi = "10.1182/blood-2008-07-165969",
language = "English",
volume = "112",
pages = "4818--4823",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "13",

}

TY - JOUR

T1 - How I treat rare venous thromboses

AU - Martinelli, Ida

AU - Franchini, Massimo

AU - Mannucci, Pier Mannuccio

PY - 2008/12/15

Y1 - 2008/12/15

N2 - Venous thromboembolism may involve venous sites other than the lower limbs, such as cerebral, splanchnic, and upper limb veins. Although uncommon, these thromboses may be clinically severe and challenging for caregivers. In this review, the main pathogenic, clinical, and therapeutic features of thromboses in rare venous sites are discussed. Even though there was a lot of recent progress in understanding the mechanistic role of inherited and acquired thrombophilia and of the interactions between different risk factors, the optimal management of these patients is still unsettled, being currently based on the consensus ofexperts due to the lack of randomized trials. The implementation of large interdisciplinary registries is a necessary weapon to optimize the treatment of rare venous diseases.

AB - Venous thromboembolism may involve venous sites other than the lower limbs, such as cerebral, splanchnic, and upper limb veins. Although uncommon, these thromboses may be clinically severe and challenging for caregivers. In this review, the main pathogenic, clinical, and therapeutic features of thromboses in rare venous sites are discussed. Even though there was a lot of recent progress in understanding the mechanistic role of inherited and acquired thrombophilia and of the interactions between different risk factors, the optimal management of these patients is still unsettled, being currently based on the consensus ofexperts due to the lack of randomized trials. The implementation of large interdisciplinary registries is a necessary weapon to optimize the treatment of rare venous diseases.

UR - http://www.scopus.com/inward/record.url?scp=58149386405&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149386405&partnerID=8YFLogxK

U2 - 10.1182/blood-2008-07-165969

DO - 10.1182/blood-2008-07-165969

M3 - Article

C2 - 18805965

AN - SCOPUS:58149386405

VL - 112

SP - 4818

EP - 4823

JO - Blood

JF - Blood

SN - 0006-4971

IS - 13

ER -